This record was last updated December 27, 2024 (before its estimated June 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
The goal of this clinical trial is to investigate the efficacy of upadacitinib after NECS in participants with vitiligo. The main question it aims to answer is: whether the short time use of upadacitinib after NECS will improve NECS efficacy. Participants in the experimental group will receive upadacitinib after NECS, while Participants in the control group will receive NECS only.
Protocol Amendment History
2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-06-06; most recent amendment 2024-12-25.
Status change: Not Yet Recruiting → Recruiting2024-12-25